SE7709797L - Sett att framstella aminoalkylidenamino-1-4-dihydropyridiner och anvendning derav som lekemedel - Google Patents

Sett att framstella aminoalkylidenamino-1-4-dihydropyridiner och anvendning derav som lekemedel

Info

Publication number
SE7709797L
SE7709797L SE7709797A SE7709797A SE7709797L SE 7709797 L SE7709797 L SE 7709797L SE 7709797 A SE7709797 A SE 7709797A SE 7709797 A SE7709797 A SE 7709797A SE 7709797 L SE7709797 L SE 7709797L
Authority
SE
Sweden
Prior art keywords
aminoalkylidenamino
dihydropyridines
drug
preparing
preparing aminoalkylidenamino
Prior art date
Application number
SE7709797A
Other languages
English (en)
Swedish (sv)
Inventor
E Wehinger
F Bossert
H Meyer
W Vater
A Heise
S Kazda
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE7709797L publication Critical patent/SE7709797L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE7709797A 1976-09-01 1977-08-31 Sett att framstella aminoalkylidenamino-1-4-dihydropyridiner och anvendning derav som lekemedel SE7709797L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762639257 DE2639257A1 (de) 1976-09-01 1976-09-01 Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
SE7709797L true SE7709797L (sv) 1978-03-02

Family

ID=5986848

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709797A SE7709797L (sv) 1976-09-01 1977-08-31 Sett att framstella aminoalkylidenamino-1-4-dihydropyridiner och anvendning derav som lekemedel

Country Status (12)

Country Link
US (1) US4146627A (ja)
JP (1) JPS6026106B2 (ja)
AT (1) AT364359B (ja)
BE (1) BE858269A (ja)
CH (1) CH634053A5 (ja)
DE (1) DE2639257A1 (ja)
ES (1) ES461994A1 (ja)
FI (1) FI60862C (ja)
FR (1) FR2363554A1 (ja)
GB (1) GB1554495A (ja)
NL (1) NL7709508A (ja)
SE (1) SE7709797L (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2835069A1 (de) * 1978-08-10 1980-02-21 Bayer Ag N-amino-3,4,5-trihydroxypiperidine, ihre herstellung und verwendung
NZ193167A (en) 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS58131982A (ja) * 1982-02-01 1983-08-06 Tokyo Tanabe Co Ltd 新規なる１．４−ジヒドロピリジン誘導体
US4419518A (en) * 1982-07-26 1983-12-06 Tokyo Tanabe Co. L.T.D. 1,4-Dihydropyridine derivatives
US4520131A (en) * 1983-03-03 1985-05-28 Usv Pharmaceutical Antihypertensive N-substituted 1,4-dihydropyridines
GR851819B (ja) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
US4652573A (en) * 1985-03-14 1987-03-24 Nelson Research & Development Co. Calcium antagonist N-hetero ester 1,4-dihydropyridines
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
US5220027A (en) * 1987-04-14 1993-06-15 Sumitomo Chemical Company, Limited Sulfone-containing azamethide compounds with a nitrogen-containing aromatic ring of nitrogen containing aliphatic
US5028708A (en) * 1987-04-14 1991-07-02 Sumitomo Chemical Company, Limited Azamethinyl quinoline derivatives
GR1002248B (en) * 1988-03-08 1996-04-23 Egyt Gyogyszervegyeszeti Gyar 1,4-dihydropyridine derivatives preparation method
DE4313696A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
JP3394215B2 (ja) 1999-07-29 2003-04-07 株式会社 日立インダストリイズ フィルム減圧貼り合わせ装置
KR100578991B1 (ko) * 2001-03-29 2006-05-12 히다치 가세고교 가부시끼가이샤 회로형성용 감광성 필름 및 프린트배선판의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946026A (en) * 1972-03-06 1976-03-23 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2239815C2 (de) * 1972-08-12 1983-02-10 Bayer Ag, 5090 Leverkusen 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
FR2363554A1 (fr) 1978-03-31
DE2639257A1 (de) 1978-03-02
ATA629677A (de) 1981-03-15
ES461994A1 (es) 1978-12-01
CH634053A5 (de) 1983-01-14
FI60862B (fi) 1981-12-31
AT364359B (de) 1981-10-12
FR2363554B1 (ja) 1980-08-08
JPS6026106B2 (ja) 1985-06-21
FI60862C (fi) 1982-04-13
JPS5331670A (en) 1978-03-25
FI772569A (fi) 1978-03-02
BE858269A (fr) 1978-02-28
NL7709508A (nl) 1978-03-03
US4146627A (en) 1979-03-27
GB1554495A (en) 1979-10-24

Similar Documents

Publication Publication Date Title
SE7601257L (sv) Bensoylureido-difenyletrar till anvendning som insekticider och sett att framstella dessa
DK271677A (da) Fremgangsmade til fremstilling af et farmaceutisk indsetningspreparat
SE7601258L (sv) Bensoylureido-nitro-difenyletrar till anvendning som insekticider och sett att framstella dessa
AR209544A1 (es) Un metodo de preparar una 2'-(carboximetoxi)-calcona
SE7709797L (sv) Sett att framstella aminoalkylidenamino-1-4-dihydropyridiner och anvendning derav som lekemedel
SE7704689L (sv) Forfarande for framstellning av insulin
SE7802378L (sv) Tetrahydrofuraneter-derivat till anvendning som herbicider och sett att framstella foreningarna
DK141586C (da) Fremgangsmaade til fremstilling af et humleoliepraeparat
SE7513011L (sv) Sett att framstella n-(trimetoxi-3,4,5-cinnamoyl)-piperazin och anvendning derav som lekemedel
SE7708621L (sv) 2-bensyl-pyrrolidiner, sett for framstellning derav och anvendning derav som lekemedel
SE7608562L (sv) Sett att framstella kernalkylerade flerkerniga fenoler och anvendning derav
DK523277A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning
SE7811582L (sv) Sett att framstella moranolin och n-metylmoranolin
FI773812A (fi) Farmaceutiska foereningar
SE7807804L (sv) Bis(nitrosoureido)-polyol-derivat och sett att framstella desamma
SE7711821L (sv) N-kloracetyl-n-fenyl-alaninestrar till anvendning som fungicider och sett att framstella foreningarna
FI772951A (fi) Zinkbacitracinkomposition foer anvaendande som fodertillsatsaemne och foerfarande foer framstaellning av den
FI773813A (fi) Farmaceutiska foereningar
SE7803167L (sv) Hydroxylerade 1alfa,2alfa-metylensteroider och sett att framstella desamma
SE7702662L (sv) Sett att framstella 2-formylaminofenylguanidin och anvendning derav som lekemedel
SE7713958L (sv) Bensimidazolderivat och sett for deras framstellning
SE7603231L (sv) Karbamat av 2-haloergoliner och 2-haloergolener och sett att framstella desamma
SE7510771L (sv) Sett att framstella furo-(3,4-b)-furan-2,4-dioner och anvendning derav som lekemedel
SE7607219L (sv) Sett att framstella penicilliner och anvendning derav som lekemedel
SE7613122L (sv) Sett att framstella 4-klor-2-butynyl-m-klorkarbanilat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7709797-0